News

Industries

Companies

Jobs

Events

People

Video

Audio

Galleries

Submit content

My Account

Advertise with us

Subscribe & Follow

Advertise your job vacancies
    Search jobs

    New drug extends liver cancer survival

    A drug called "sorafenib" -- sold under the brand name Nexavar -- stops the growth of tumors in people with liver cancer, a particularly hard-to-treat disease, according to a recent study.

    Nexavar, marketed by Bayer Pharmaceuticals and Onyx Pharmaceuticals, is approved in the U.S. and dozens of other countries to treat advanced kidney cancer.

    Read the full article

    More news
    Let's do Biz